Skip to main content

ALD Gene Mutation clinical trials at UCSF

1 research study open to eligible people

An ALD gene mutation is a change in the gene ABCD1 that affects how nerves stay insulated. UCSF is collecting samples and health records for a myelin disorders biorepository. UCSF is also measuring genes, blood markers, and brain scans in research studies.

Showing trials for
  • Myelin Disorders Biorepository Project

    open to all eligible people

    The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.

    San Francisco, California and other locations

Last updated: